Paper Details

  1. Home
  2. Paper Details

Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia.

Author: ChiapelliJoshua, FischerBernard A, HimelhochSeth, ReeseCarla, VidalCarol

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

The meta-analysis assessed the efficacy of mirtazapine as an adjunctive treatment for negative symptoms in schizophrenia. Adding mirtazapine to antipsychotic treatment resulted in improvement in negative symptoms. Further studies are needed with more stringent selection criteria and homogeneous use of antipsychotics.
Paper Details　
Original Abstract of the Article :
CONTEXT: Despite advances made in treating the positive symptoms of schizophrenia, treatment of negative symptoms remains an unmet therapeutic need. Adjunctive mirtazapine has shown promise for treatment of negative symptoms in several small clinical trials. OBJECTIVE: To assess the efficacy of mir...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3371/CSRP.VIRE.030813

データ提供：米国国立医学図書館（NLM）

Mirtazapine: A Potential Adjunct for Treating Negative Symptoms in Schizophrenia

The desert of schizophrenia can be a lonely and challenging landscape, with negative symptoms often proving particularly difficult to treat. This meta-analysis explores the efficacy of mirtazapine as an adjunctive treatment for negative symptoms in schizophrenia. The authors conducted a systematic review of randomized controlled trials evaluating the use of mirtazapine as an adjunct to antipsychotic medication in patients with schizophrenia.

Mirtazapine Shows Promise for Negative Symptoms in Schizophrenia

The meta-analysis revealed that adding mirtazapine to antipsychotic medication led to significant improvement in negative symptoms in schizophrenia. The authors noted that the overall analysis showed a statistically significant effect size, suggesting that mirtazapine may be a valuable tool for addressing negative symptoms in this challenging disorder. This research suggests that mirtazapine could play a significant role in enhancing treatment outcomes for individuals with schizophrenia, potentially leading to improved quality of life and social functioning.

The Importance of Addressing Negative Symptoms

This meta-analysis underscores the importance of addressing negative symptoms in schizophrenia, which can have a profound impact on social functioning and overall well-being. The study encourages further research to explore the optimal use of mirtazapine in treating negative symptoms, identifying potential predictors of response and refining treatment strategies. It's like discovering a hidden oasis of hope in the vast desert of schizophrenia, offering potential relief from the debilitating effects of negative symptoms.

Dr. Camel's Conclusion

This meta-analysis provides a glimmer of hope in the desert of schizophrenia. The findings suggest that mirtazapine, when added to antipsychotic medication, may offer a valuable tool for addressing negative symptoms, leading to improved quality of life and social functioning. This research encourages further exploration of mirtazapine's potential in treating schizophrenia, potentially leading to new paths to recovery and well-being.
Date :
  1. Date Completed 2016-05-05
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

23491969

DOI: Digital Object Identifier

10.3371/CSRP.VIRE.030813

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.